NKGen Biotech, Inc. Common Stock
Save
17.58M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses.

Similar securities

Based on sector and market capitalization

Report issue